Medtronic (NYSE:MDT) has had a rough three months with its share price down 6.5%. To decide if this trend could continue, we decided to look at its weak fundamentals as they shape the long-term market ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 times ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...